1. Home
  2. CPHI vs CHNR Comparison

CPHI vs CHNR Comparison

Compare CPHI & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPHI
  • CHNR
  • Stock Information
  • Founded
  • CPHI N/A
  • CHNR N/A
  • Country
  • CPHI China
  • CHNR China
  • Employees
  • CPHI N/A
  • CHNR N/A
  • Industry
  • CPHI Biotechnology: Pharmaceutical Preparations
  • CHNR Precious Metals
  • Sector
  • CPHI Health Care
  • CHNR Basic Materials
  • Exchange
  • CPHI Nasdaq
  • CHNR Nasdaq
  • Market Cap
  • CPHI 4.7M
  • CHNR 5.3M
  • IPO Year
  • CPHI N/A
  • CHNR 1995
  • Fundamental
  • Price
  • CPHI $1.78
  • CHNR $6.38
  • Analyst Decision
  • CPHI
  • CHNR
  • Analyst Count
  • CPHI 0
  • CHNR 0
  • Target Price
  • CPHI N/A
  • CHNR N/A
  • AVG Volume (30 Days)
  • CPHI 14.2K
  • CHNR 992.5K
  • Earning Date
  • CPHI 11-12-2025
  • CHNR 11-11-2025
  • Dividend Yield
  • CPHI N/A
  • CHNR N/A
  • EPS Growth
  • CPHI N/A
  • CHNR N/A
  • EPS
  • CPHI N/A
  • CHNR N/A
  • Revenue
  • CPHI $4,396,201.00
  • CHNR N/A
  • Revenue This Year
  • CPHI N/A
  • CHNR N/A
  • Revenue Next Year
  • CPHI N/A
  • CHNR N/A
  • P/E Ratio
  • CPHI N/A
  • CHNR N/A
  • Revenue Growth
  • CPHI N/A
  • CHNR N/A
  • 52 Week Low
  • CPHI $1.20
  • CHNR $3.16
  • 52 Week High
  • CPHI $3.35
  • CHNR $8.20
  • Technical
  • Relative Strength Index (RSI)
  • CPHI 46.82
  • CHNR 60.48
  • Support Level
  • CPHI $1.64
  • CHNR $5.77
  • Resistance Level
  • CPHI $1.93
  • CHNR $6.43
  • Average True Range (ATR)
  • CPHI 0.08
  • CHNR 0.80
  • MACD
  • CPHI -0.03
  • CHNR -0.00
  • Stochastic Oscillator
  • CPHI 38.89
  • CHNR 46.47

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

About CHNR China Natural Resources Inc.

China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.

Share on Social Networks: